Interstitial lung disease and diabetes

Area of Science:

• Pulmonology
• Endocrinology
• Pathology

Background:

• Diabetes mellitus (DM) is a global chronic metabolic disease with increasing prevalence.
• DM complications include microvascular (retinopathy, neuropathy, nephropathy) and macrovascular (cardiovascular) issues.
• The lungs are also affected by DM due to vascularity and connective tissue, leading to restrictive lung function decline.

Purpose of the Study:

• To review the lung as a target organ in diabetes mellitus.
• To explore the association between DM and interstitial lung disease (ILD).
• To emphasize the specific link between DM and idiopathic pulmonary fibrosis (IPF).

Main Methods:

• Literature review focusing on DM and lung pathology.
• Analysis of studies investigating DM-associated microvascular changes in the lungs.
• Examination of research on fibrosis and connective tissue proliferation in diabetic lungs.

Main Results:

• DM can cause microvascular complications and extracellular matrix proliferation in the lungs.
• This can lead to a decline in lung function, often presenting as a restrictive pattern.
• Interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), is a significant concern in diabetic patients.

Conclusions:

• The lungs are a significant target organ for diabetes mellitus complications.
• There is a demonstrable association between DM and the development or exacerbation of ILD, particularly IPF.
• Further research is warranted to elucidate the mechanisms and clinical implications of DM-ILD/IPF association.